Literature DB >> 36068255

The effect of the association between CETP variant type and alcohol consumption on cholesterol level differs according to the ALDH2 variant type.

Min-Gyu Yoo1, Ji Ho Yun1, Soo Kyung Koo1, Hye-Ja Lee2.   

Abstract

Alcohol consumption is associated with a high increased lipid profile and this association may depend on genetic risk factors. In this study, we aimed to assess the effects of genetic variation associated with alcohol consumption on lipid profiles using data from two Korean population studies. We performed a genotype association study using the HEXA (n = 51,349) and KNHANES (n = 9158) data. Genotype analyses of the two sets of Korean population data showed associations of increased total cholesterol and high-density lipoprotein (HDL)-cholesterol with CETP rs708272. The HEXA and KNHANES populations revealed differences in HDL cholesterol according to the presence of CETP rs708272, independent of ALDH2 rs671 and alcohol consumption. In contrast, total cholesterol levels were associated with alcohol consumption and ALDH2 rs671 in men with CETP rs708272 (CT and TT genotypes). Furthermore, in drinkers with ALDH2 rs671 (GA and AA genotypes), higher total cholesterol was associated with the CETP rs708272 TT minor homozygous genotype based on both HEXA and KNHANES data. Our findings demonstrated that alcohol consumption and genetic variation in either CETP or ALDH2 may be associated with cholesterol levels. We hope these findings will provide a better understanding of the relationship between alcohol consumption and cholesterol according to each individual's genetic background.
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36068255      PMCID: PMC9448738          DOI: 10.1038/s41598-022-19171-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


Introduction

Alcohol consumption is a major environmental factor that is associated with health problems. Greater alcohol consumption exacerbates the lipid profile[1], which has been linked to various diseases, including dyslipidemia and cardiovascular diseases[2,3]. Previous studies have reported that alcohol consumption is associated with improved high-density lipoprotein cholesterol (HDL-C) levels, but also with increased triglyceride (TGs)[4] and low-density lipoprotein (LDL)[5]. The association between alcohol consumption and total cholesterol remains controversial, with several studies either showing no effect[6] or increased cholesterol levels. Thus, it is necessary to clarify the association between alcohol consumption and lipid profiles and the related mechanisms in large groups representing various races/ethnicities. Cholesterol levels are associated with both genetic and environmental factors. Among them, cholesteryl ester transfer protein (CETP; also called plasma lipid transfer protein), which circulates in plasma, is mainly bound to HDL-C and facilitates the transfer of cholesteryl ester particles to apolipoprotein B (including LDL and very low-density lipoprotein (V-LDL)) in exchange for TGs[7]. In general, changes in the activity and concentration of CETP decrease the plasma HDL-C levels and increase the plasma LDL-cholesterol (LDL-C) levels. Additionally, genetic variations are related to its regulation[8]. CETP rs708272 (also called Taq1B) is a C-to-T substitution at the 279th nucleotide of intron 1 and is the most thoroughly studied variant of this gene. A previous study identified an association between increased HDL-C levels or decreased CETP activity and allele type (B1, B2)[9,10]. Allele B1 affects the size and function of the CETP protein and HDL-C level. In contrast, allele B2 is associated with lower-molecular-weight CETP and increased HDL-C. Moreover, increased HDL-C levels were associated with reduced CETP activity due to alcohol consumption[11], and high alcohol consumption increased HDL-C levels in B2 carriers[12]. Facial flushing in response to alcohol consumption, known as Asian flushing or the Asian glow, is a reaction specific to East Asian populations[13]. This response can estimate the activities of ALDH2 and ADH1B, which are the most efficient enzymes associated with aldehydes. Higher activity of ADH (conferred by Arg48) or lower activity of ALDH2 (conferred by Lys487) leads to accumulation of acetaldehyde following alcohol consumption. In particular, the ALDH2 rs671 variant slows the degradation of acetaldehyde, and the accumulated acetaldehyde can cause serious inconvenience. In addition, ALDH2 rs671 had different effects on HDL-C and total cholesterol according to genotype; lower HDL-C and higher total cholesterol levels were observed with the ALDH2 rs671 genotype when compared to those observed in its absence[14]. Furthermore, carriers with the ALDH2 rs671 GG genotype had substantially higher mean alcohol consumption and HDL-C levels than those with the other genotypes[15]. The GG genotype carriers in the Shandong province of China had a higher mean lipid level and total cholesterol disorder rate than those of the other genotype carriers[16]. In this regard, ALDH2 variation should be considered as the main genetic proxy for the differences in cholesterol according to alcohol consumption. Moreover, it is important in alcohol research because of its direct relation to alcohol metabolism. However, few studies have addressed the influence of alcohol consumption on cholesterol according to CETP and ALDH2 variant type status. Accordingly, we aimed to investigate the association between alcohol consumption and cholesterol according to CETP and ALDH2 variants in the Korean population.

Results

Data were obtained from the Health Examinees Study (HEXA) and Korean National Health and Nutrition Examination Survey (KNHANES). The characteristics of the study participants, according to sex, are presented in Table 1. Age, systolic/diastolic blood pressure, fasting glucose level, total cholesterol level, HDL-C level, TG level, aspartate transaminase (AST) level, alanine transaminase (ALT) level, and alcohol consumption rate differed by sex in both the HEXA and KNHANES study populations (p < 0.05). The frequency of ALDH2 rs671 differed significantly by sex in the HEXA population, but not in the KNHANES population. The general characteristics of age, systolic/diastolic blood pressure, HDL-C level, TG level, and AST and ALT levels differed according to alcohol consumption in both study populations (Online Supplementary Table S1).
Table 1

General characteristics of Korean population.

TotalMenWomenp-value
HEXA
Subject (n, %)53,605(100.0)18,482(34.5)35,123(65.5)
Age (years)53.8 ± 8.055.2 ± 8.453.1 ± 7.7 < 0.0001
Systolic blood pressure (mmHg)122.5 ± 14.8125.6 ± 14.1120.8 ± 14.9 < 0.0001
Diastolic blood pressure (mmHg)75.8 ± 9.778.3 ± 9.574.5 ± 9.5 < 0.0001
Fasting glucose (mg/dL)95.0 ± 19.699.1 ± 22.192.8 ± 17.8 < 0.0001
Total cholesterol (mg/dL)197.4 ± 35.7192.3 ± 34.9200.1 ± 35.8 < 0.0001
HDL-cholesterol (mg/dL)53.8 ± 13.149.2 ± 11.956.2 ± 13.1 < 0.0001
LDL-cholesterol (mg/dL)119.3 ± 32.2114.8 ± 31.5121.7 ± 32.3 < 0.0001
Triglycerides (mg/dL)125.1 ± 85.6147.6 ± 101.7113.3 ± 73.0 < 0.0001
AST (IU/L)23.7 ± 23.225.4 ± 12.822.8 ± 27.1 < 0.0001
ALT (IU/L)22.4 ± 22.826.5 ± 18.820.2 ± 24.3 < 0.0001
Alcohol consumption (Drinker, %)23,751(44.3)13,177(71.3)10,574(30.1) < 0.0001
CETP rs708272
CC20,523(38.3)7,122(38.5)13,401(38.2)0.4276
CT25,225(47.1)8,698(47.1)16,527(47.1)
TT7,857(14.7)2,662(14.4)5,195(14.8)
ALDH2 rs671
GG37,794(70.7)12,904(69.9)24,890(71.1)0.0204
GA14,443(27.0)5,094(27.6)9,349(26.7)
AA1,241(2.3)541(2.4)790(2.3)
KNHANES
Subject (n, %)14,133(100.0)6,893(48.8)7,240(51.2)
Age (years)46.6 ± 16.547.0 ± 17.046.3 ± 16.0 < 0.0001
Systolic blood pressure (mmHg)117.6 ± 16.2120.4 ± 15.2114.9 ± 16.7 < 0.0001
Diastolic blood pressure (mmHg)75.4 ± 10.577.7 ± 10.473.3 ± 9.7 < 0.0001
Fasting glucose (mg/dL)98.4 ± 21.7100.8 ± 23.296.1 ± 19.9 < 0.0001
Total cholesterol (mg/dL)188.0 ± 36.1186.3 ± 35.4189.6 ± 35.5 < 0.0001
HDL-cholesterol (mg/dL)50.6 ± 12.247.5 ± 11.353.5 ± 12.4 < 0.0001
LDL-cholesterol (mg/dL)117.5 ± 34.0114.8 ± 34.0120.9 ± 33.6 < 0.0001
Triglycerides (mg/dL)135.5 ± 111.7156.9 ± 131.6115.0 ± 83.9 < 0.0001
AST (IU/L)22.4 ± 13.124.3 ± 13.520.5 ± 12.2 < 0.0001
ALT (IU/L)21.9 ± 19.025.9 ± 21.318.0 ± 15.6 < 0.0001
Alcohol consumption (Drinker, %)12,544(88.8)6,422(93.2)6,122(84.6) < 0.0001
CETP rs708272
CC5,481(38.8)5,481(38.8)2,844(39.3)0.2496
CT6,589(46.6)3,263(47.3)3,326(45.9)
TT2.063(14.6)993(14.4)1,070(14.8)
ALDH2 rs671
GG10,028(71.6)4,852(70.5)5,176(71.6)0.3302
GA3,737(26.5)1,861(27.0)1,876(26.0)
AA347(2.5)171(2.5)176(50.7)

All data except alcohol consumption, CETP and ALDH2 genotype are represented as means ± standard deviation. Student’s t-test and chi-square tests were used to determine differences between men and women.

HDL high-density lipoprotein, AST aspartate aminotransferase, ALT alanine aminotransferase.

General characteristics of Korean population. All data except alcohol consumption, CETP and ALDH2 genotype are represented as means ± standard deviation. Student’s t-test and chi-square tests were used to determine differences between men and women. HDL high-density lipoprotein, AST aspartate aminotransferase, ALT alanine aminotransferase. The participants’ clinical characteristics are summarized according to CETP rs708272 [CC, CT, or TT] status in Table 2. The total cholesterol and HDL-C levels of CETP rs708272 risk T allele carriers were significantly higher than others in the HEXA and KNHANES populations (p < 0.05). In addition, the risk allele T carriers had a higher LDL-C levels in the KNHANES study (p < 0.05). When categorized by sex, LDL-C levels were significantly different between men in both the HEXA and KNHANES studies. (Online Supplementary Tables S2 and S3). Men carrying CETP rs708272 TT allele had higher LDL-C levels than those carrying the CT of the TT genotype. On the other hand, almost all general characteristics according to the ALDH2 rs671 genotype, except for sex and total cholesterol, showed differences in both study populations (Online Supplementary Table S4).
Table 2

General characteristics of subjects according to CETP genotype in HEXA and KNHANES.

CETPp value
CCCTTT
HEXA
Subject (n, %)20,523(38.3)25,225(47.1)7,857(14.7)
Age (years)53.8 ± 8.053.8 ± 8.053.9 ± 8.00.8017
Sex (male)7,122(34.7)8,698(34.5)2.662(33.9)0.4276
Systolic blood pressure (mmHg)122.5 ± 14.8122.4 ± 14.8122.5 ± 14.70.6488
Diastolic blood pressure (mmHg)75.8 ± 9.775.8 ± 9.775.8 ± 9.80.6183
Fasting glucose (mg/dL)95.0 ± 19.894.9 ± 19.794.9 ± 18.50.8042
Total cholesterol (mg/dL)196.1 ± 35.5197.7 ± 35.8200.0 ± 35.9 < 0.0001
HDL-cholesterol (mg/dL)52.2 ± 12.654.3 ± 13.256.4 ± 13.8 < 0.0001
LDL-cholesterol (mg/dL)119.3 ± 32.0119.3 ± 32.3119.6 ± 32.10.6610
Triglycerides (mg/dL)126.9 ± 86.5124.2 ± 85.1123.2 ± 84.40.0004
AST (IU/L)23.9 ± 33.223.7 ± 13.823.6 ± 13.30.5443
ALT (IU/L)22.6 ± 29.322.3 ± 17.222.3 ± 18.80.3703
Alcohol consumption (Drinker, %)9,051(44.1)11.218(44.8)3,482(44.3)0.2054
KNHANES
Subject (n, %)5,802(38.9)6,949(46.5)2,180(14.6)
Age (years)46.5 ± 16.946.7 ± 16.846.4 ± 16.60.6785
Sex (male)2,783(48.0)3,450(50.0)1,048(48.1)0.1310
Systolic blood pressure (mmHg)117.5 ± 16.5117.7 ± 16.3117.6 ± 15.90.7698
Diastolic blood pressure (mmHg)75.2 ± 10.675.3 ± 10.575.4 ± 10.60.6617
Fasting glucose (mg/dL)98.5 ± 22.298.5 ± 22.098.8 ± 22.50.8674
Total cholesterol (mg/dL)185.8 ± 36.1188.6 ± 36.3191.4 ± 35.9 < 0.0001
HDL-cholesterol (mg/dL)49.3 ± 11.950.9 ± 12.352.7 ± 12.3 < 0.0001
LDL-cholesterol (mg/dL)115.0 ± 33.7119.2 ± 34.1118.5 ± 33.8 < 0.0001
Triglycerides (mg/dL)135.2 ± 114.1134.9 ± 107.3137.0 ± 115.80.7352
AST (IU/L)22.7 ± 15.822.3 ± 11.622.3 ± 10.70.1381
ALT (IU/L)22.2 ± 22.921.6 ± 16.822.0 ± 17.30.2100
Alcohol consumption (Drinker, %)3,842(66.2)4,654(67.0)1,432(65.7)0.4605

All data except alcohol consumption and sex are represented as means ± standard deviation. General linear models and chi-square tests were used to determine differences between CETP genotype.

HDL high-density lipoprotein, AST aspartate aminotransferase, ALT alanine aminotransferase.

General characteristics of subjects according to CETP genotype in HEXA and KNHANES. All data except alcohol consumption and sex are represented as means ± standard deviation. General linear models and chi-square tests were used to determine differences between CETP genotype. HDL high-density lipoprotein, AST aspartate aminotransferase, ALT alanine aminotransferase. Table 3 shows the total cholesterol and HDL-C levels according to alcohol consumption in carriers of CETP rs708272. HDL-C levels differed significantly between CETP rs708272 by alcohol consumption and sex in the HEXA and KNHANES study populations. In the HEXA population, CETP rs708272 was associated with a higher HDL-C level in drinkers than in non-drinkers of both sexes. However, HDL-C level did not differ with the association between the CETP rs708272 TT minor homozygous genotype and alcohol consumption in both sexes in the KNHANES population. In the HEXA population, total cholesterol varied significantly with alcohol consumption in men with CETP rs708272, whereas in women, there was no association between drinking and CETP rs708272. In addition, in the KNHANES population, total cholesterol was not associated with CETP rs708272 among non-drinkers and drinkers. In the HEXA population, total cholesterol differed significantly among men with CETP rs708272 depending on alcohol consumption. In contrast, the KNHANES population, there was no association between drinking status and CETP rs708272. In addition, CETP rs708272 was associated with higher total cholesterol levels in male drinkers than in non-drinkers in the HEXA population, whereas no association was found in the KNHANES population. In women, total cholesterol differed significantly among CETP rs708272 in non-drinkers in both the HEXA and KNHANES populations. Total cholesterol was inversely associated with alcohol consumption according to CETP rs708272 in the HEXA population. However, the only risk TT minor homozygous genotype of CETP rs708272 was inversely associated with higher total cholesterol in drinkers in the KNHANES population. Conversely, the association of cholesterol with alcohol consumption in the CETP rs708272 major homozygous genotype group disappeared.
Table 3

Association between alcohol consumption and cholesterol (HDL and total) according to CETP genotype.

CETPp value1
CCCTTT
HEXA
HDL-cholesterol
Total
Non-drinker52.2 ± 12.354.3 ± 12.856.4 ± 13.4 < 0.0001
Drinker52.5 ± 13.054.8 ± 13.756.7 ± 14.1 < 0.0001
p value20.04680.01560.3931
Men
Non-drinker44.9 ± 10.246.7 ± 11.048.4 ± 11.2 < 0.0001
Drinker48.6 ± 11.451.1 ± 12.453.0 ± 12.7 < 0.0001
p value2 < 0.0001 < 0.0001 < 0.0001
Women
Non-drinker53.4 ± 12.255.5 ± 12.657.6 ± 13.3 < 0.0001
Drinker57.4 ± 13.259.4 ± 13.861.2 ± 14.5 < 0.0001
p value2 < 0.0001 < 0.0001 < 0.0001
Total cholesterol
Total
Non-drinker197.3 ± 35.7199.0 ± 36.1201.3 ± 35.9 < 0.0001
Drinker195.3 ± 34.9197.1 ± 35.2198.8 ± 35.8 < 0.0001
p value2 < 0.0001 < 0.00010.0026
Men
Non-drinker187.3 ± 35.0190.1 ± 35.6193.3 ± 34.50.0017
Drinker192.1 ± 34.0194.6 ± 34.4197.4 ± 35.7 < 0.0001
p value2 < 0.0001 < 0.00010.0159
Women
Non-drinker199.0 ± 35.5200.4 ± 36.0202.6 ± 35.9 < 0.0001
Drinker199.3 ± 35.6200.3 ± 36.0200.6 ± 35.90.2872
p value20.72600.85840.0659
KNHANES
HDL-cholesterol
Total
Non-drinker48.3 ± 11.250.2 ± 11.652.7 ± 11.7 < 0.0001
Drinker48.0 ± 12.149.8 ± 12.451.3 ± 12.7 < 0.0001
p value20.52590.33070.0548
Men
Non-drinker41.9 ± 8.845.0 ± 10.147.2 ± 9.30.0342
Drinker45.5 ± 11.047.4 ± 11.749.6 ± 12.2 < 0.0001
p value20.00530.03660.3846
Women
Non-drinker47.5 ± 10.250.0 ± 53.753.7 ± 10.1 < 0.0001
Drinker51.4 ± 12.353.0 ± 12.353.6 ± 12.9 < 0.0001
p value2 < 0.0001 < 0.00010.9451
Total cholesterol
Total
Non-drinker189.4 ± 33.6191.0 ± 33.9198.7 ± 34.8 < 0.0001
Drinker189.9 ± 34.4192.5 ± 35.0193.9 ± 33.70.0025
p value20.74710.22120.0227
Men
Non-drinker184.4 ± 35.1184.9 ± 30.0187.6 ± 27.50.9300
Drinker184.1 ± 32.4186.1 ± 32.1188.9 ± 27.90.0078
p value20.95410.71860.8351
Women
Non-drinker189.7 ± 34.2197.2 ± 36.9207.3 ± 37.8 < 0.0001
Drinker195.8 ± 34.9197.6 ± 35.9198.9 ± 37.40.1620
p value20.00430.81900.0205

Data are expressed as means ± standard deviations.

1General linear models were used to assess differences in variables between CETP genotype.

2Student’s t-test was used to assess difference in a variable between alcohol consumption in each CETP genotype.

Association between alcohol consumption and cholesterol (HDL and total) according to CETP genotype. Data are expressed as means ± standard deviations. 1General linear models were used to assess differences in variables between CETP genotype. 2Student’s t-test was used to assess difference in a variable between alcohol consumption in each CETP genotype. In the case of ALDH2 rs671, HDL-C showed a significant difference according to the ALDH2 rs671 genotype in non-drinkers and drinkers in the HEXA population. Nevertheless, only drinkers showed differences in the KNHANES population. Moreover, ALDH2 rs671 [GA + AA] genotype was associated with lower HDL-C levels in drinkers than those in non-drinkers in the HEXA population. Total cholesterol in the HEXA and KNHANES populations differed according to the ADLH2 rs671 genotype in drinkers (Online Supplementary Table S5). The effects of CETP rs708272 and alcohol consumption on HDL-C according to ALDH2 rs671 are shown in Table 4 and Online Supplementary Fig. S1. HDL-C differed significantly according to CETP rs708272 independent of ALDH2 rs671 and alcohol consumption, but CETP rs708272 and HDL-C were slightly associated with the ALDH2 rs671 [GA + AA] genotypes. In addition, those with the ALDH2 rs671 [GA + AA] genotype exhibited trends toward lower HDL-C compared with those with the ALDH2 rs671 GG major homozygous genotype. Still, overall, the HDL-C level was higher in men drinkers than in non-drinkers, regardless of the ALDH2 rs671 genotype.
Table 4

Effects of CETP genotype and alcohol consumption on HDL-cholesterol according to ALDH2 genotype.

ALDH2(GG)ALDH2(GA + AA)p value1
Non-drinkerDrinkerNon-drinkerDrinker
HEXA
Total
CC52.7 ± 12.553.0 ± 13.151.5 ± 12.050.1 ± 12.0 < 0.0001
CT55.0 ± 12.855.2 ± 13.753.4 ± 12.752.4 ± 12.9 < 0.0001
TT57.0 ± 13.357.0 ± 14.355.6 ± 13.654.9 ± 13.1 < 0.0001
p value2 < 0.0001 < 0.0001 < 0.0001 < 0.0001
Men
CC45.6 ± 11.149.0 ± 11.544.6 ± 9.747.2 ± 10.6 < 0.0001
CT47.9 ± 11.651.4 ± 12.546.0 ± 10.649.6 ± 11.5 < 0.0001
TT49.6 ± 12.553.2 ± 12.847.9 ± 10.552.3 ± 12.5 < 0.0001
p value < 0.0001 < 0.0001 < 0.0001 < 0.0001
Women
CC53.3 ± 12.557.5 ± 13.353.5 ± 11.856.7 ± 12.5 < 0.0001
CT55.6 ± 12.759.5 ± 13.855.4 ± 12.458.9 ± 13.6 < 0.0001
TT57.6 ± 13.261.3 ± 14.757.8 ± 13.660.9 ± 12.7 < 0.0001
p value < 0.0001 < 0.0001 < 0.00010.0006
KNHANES
Total
CC46.6 ± 9.949.0 ± 12.346.3 ± 10.546.4 ± 11.1 < 0.0001
CT49.3 ± 11.150.6 ± 12.448.8 ± 11.148.4 ± 11.9 < 0.0001
TT53.1 ± 11.252.1 ± 12.752.7 ± 9.450.0 ± 12.70.0566
p value < 0.0001 < 0.0001 < 0.0001 < 0.0001
Men
CC39.9 ± 11.146.4 ± 11.442.2 ± 8.443.5 ± 9.7 < 0.0001
CT46.7 ± 11.148.4 ± 11.944.3 ± 9.844.9 ± 10.7 < 0.0001
TT50.5 ± 5.450.5 ± 12.446.4 ± 10.047.3 ± 11.40.0239
p value0.1561 < 0.00010.18830.0002
Women
CC47.1 ± 9.751.8 ± 12.548.0 ± 10.750.3 ± 11.6 < 0.0001
CT49.7 ± 11.153.0 ± 12.450.4 ± 11.253.2 ± 11.80.0002
TT53.2 ± 11.453.7 ± 12.754.2 ± 8.753.3 ± 13.30.9532
p value0.00030.00900.00030.0018

Data are expressed as means ± standard deviations.

1General linear models by CETP genotypes in each group, and differences between alcohol consumption and ALDH2 genotype.

2General linear models were used to assess CETP genotype differences in variables between alcohol consumption and HDL-cholesterol by ALDH2 genotype.

Effects of CETP genotype and alcohol consumption on HDL-cholesterol according to ALDH2 genotype. Data are expressed as means ± standard deviations. 1General linear models by CETP genotypes in each group, and differences between alcohol consumption and ALDH2 genotype. 2General linear models were used to assess CETP genotype differences in variables between alcohol consumption and HDL-cholesterol by ALDH2 genotype. Table 5 shows the association of total cholesterol with alcohol consumption and ALDH2 rs671 according to CETP rs708272. In men, total cholesterol was associated with alcohol consumption and ADLH2 rs671 when CETP rs708272 CT heterozygous and TT minor homozygous genotypes were present in both HEXA and KNHANES populations. Additionally, drinkers with ALDH2 rs671 exhibited the highest total cholesterol level with the CETP rs708272 TT risk minor homozygous genotype in both the HEXA and KNHANES populations. On the other hand, as a result of analyzing the association between the CETP rs708272 genotype and alcohol consumption according to ALDH2 variation in women, the total cholesterol level was high in the presence of the CETP rs708272 risk T allele, but there was no significant difference, unlike in men. In particular, male drinkers with the CETP rs708272 TT risk minor homozygous genotype had the highest total cholesterol level when they had the ALDH2 rs671 [GA + AA] genotype.
Table 5

Effects of CETP genotype and alcohol consumption on total cholesterol according to ALDH2 genotype.

ALDH2(GG)ALDH2(GA + AA)p value1
Non-drinkerDrinkerNon-drinkerDrinker
HEXA
Total
CC197.3 ± 35.5195.7 ± 35.0197.2 ± 35.9193.2 ± 34.4 < 0.0001
CT199.3 ± 36.4197.6 ± 35.2201.7 ± 35.8200.3 ± 34.2 < 0.0001
TT201.1 ± 35.9198.5 ± 36.2201.7 ± 35.8200.3 ± 34.20.0121
p value2) < 0.00010.0001 < 0.00010.0002
Men
CC185.0 ± 34.0192.7 ± 34.4188.5 ± 35.5190.1 ± 32.4 < 0.0001
CT188.1 ± 35.2194.8 ± 34.5191.2 ± 35.7193.9 ± 34.2 < 0.0001
TT189.2 ± 31.6196.5 ± 36.1195.1 ± 35.6200.9 ± 33.80.0031
p value2)0.20190.00040.0069 < 0.0001
Women
CC198.5 ± 35.4199.1 ± 35.4199.8 ± 35.6200.0 ± 37.70.3288
CT200.3 ± 36.3200.7 ± 35.8200.6 ± 35.3196.8 ± 37.00.1015
TT202.0 ± 36.0200.7 ± 36.1203.5 ± 35.7199.0 ± 35.20.1479
p value20.00020.10650.00570.3711
KNHANES
Total
CC189.0 ± 35.2189.5 ± 34.4188.6 ± 33.8190.8 ± 33.60.7448
CT195.8 ± 36.4191.1 ± 34.0193.9 ± 35.6193.2 ± 35.80.0959
TT199.0 ± 35.2192.8 ± 34.2210.1 ± 38.4197.3 ± 31.1 < 0.0001
p value20.07380.0477 < 0.00010.0209
Men
CC173.3 ± 29.3182.8 ± 31.4185.9 ± 35.8187.2 ± 34.30.0641
CT181.1 ± 32.7184.7 ± 30.5186.2 ± 29.2189.4 ± 35.20.0304
TT185.0 ± 38.4186.4 ± 28.7188.3 ± 25.5195.3 ± 24.40.0125
p value20.78110.09830.96910.0437
Women
CC189.9 ± 35.4196.0 ± 35.8189.6 ± 33.1195.6 ± 32.10.0400
CT197.8 ± 36.5197.4 ± 36.0196.5 ± 37.3198.4 ± 35.90.9386
TT199.8 ± 35.2198.8 ± 37.7214.6 ± 39.2199.5 ± 36.80.0146
p value20.05950.3612 < 0.00010.4070

Data are expressed as means ± standard deviations.

1General linear models by CETP genotypes in each group, and differences between alcohol consumption and ALDH2 genotype.

2General linear models were used to assess CETP genotype differences in variables between alcohol consumption and total cholesterol by ALDH2 genotype.

Effects of CETP genotype and alcohol consumption on total cholesterol according to ALDH2 genotype. Data are expressed as means ± standard deviations. 1General linear models by CETP genotypes in each group, and differences between alcohol consumption and ALDH2 genotype. 2General linear models were used to assess CETP genotype differences in variables between alcohol consumption and total cholesterol by ALDH2 genotype.

Discussion

Several studies have reported associations between CETP rs708272, alcohol consumption, and cholesterol levels. In addition, ALDH2 rs671, which is closely related to alcohol consumption in East Asians, is well known to be associated with HDL-c according to alcohol consumption[17], but studies involving CETP variants have not been reported. We investigated the association between alcohol consumption and cholesterol levels according to CETP and ALDH2 variants and their combinations in two large-scale Korean populations. Previous studies have shown that CETP rs708272 increases HDL-C levels. In a meta-analysis of 98 published studies[18], CETP rs708272 was associated with higher mean HDL-C levels. In that study, HDL-C level was higher in the CETP rs708272 risk allele (TT and CT genotype) carriers than in the CC major homozygous genotype carriers. In 2018, Cai et. al. reported that the HDL level of participants with CETP rs708272 TT genotype was higher than those of CC genotype, and the HDL level of male participants with only T allele was significantly higher[19]. Also, some studies have shown a gene × alcohol consumption interaction for CETP. Based on the limited evidence, alcohol consumption appears to be associated with lower CETP activity[20]. In the association between alcohol consumption and HDL-C, changes in other metabolic pathways including an increased transport rate of apolipoproteins, reduced hepatic lipase activity, and so on may be likely[21-25]. However, our study found no interaction between CETP rs708272 and alcohol consumption in determining HDL-C. This is in line with previous studies carried out in a Mediterranean population[26], healthy men[27], and insulin-dependent men[28]. The metabolic mechanisms underlying an increase in HDL-C following the interaction between CETP and alcohol consumption are poorly understood, and more research is needed. In this study, we observed that increased HDL-C was associated with alcohol consumption independent of ALDH2 rs671; this result is similar to that of a previous meta-analysis, which revealed an association between alcohol consumption and HDL-C. However, Wakabayashi et al. reported that the effect of alcohol consumption on HDL-C was different in drinkers with an alcohol flushing response[29]. The beneficial effects of an association between alcohol consumption and HDL-C according to ALDH2 rs671 remains controversial because several other studies have shown that HDL-C is influenced by alcohol consumption differently in drinkers with an alcohol flushing response. According to some data, the ALDH2 rs671 A allele carriers, GA, and AA genotypes have a 2.6-fold higher risk of hypo-HDL-cholesterolemia than the GG homozygous genotype[30]. These conflicting findings may be due to the small size of the study population. Further studies using larger populations are needed to clarify whether ALDH2 affects the relationship between alcohol consumption and HDL-C. The effects of alcohol consumption on total cholesterol may differ according to the CETP or ALDH2 status. Previous studies have shown that alcohol consumption in subjects with the ALDH2 rs671 risk A allele was associated with increased total cholesterol compared to alcohol consumption with the ALDH2 rs671 GG homozygous genotype[31]. Similar to previous studies, our study found that drinkers with the ALDH2 [GA + AA] genotype had higher total cholesterol levels than non-drinkers with the ALDH2 GG homozygous genotype. CETP variants also showed an association with total cholesterol increase[32], but no significant difference was found in total cholesterol levels according to alcohol consumption in CETP rs708272[33]. The total cholesterol levels in our study were the highest in both men and women with CETP rs708272 risk TT genotype. Still, there was no difference according to ALDH2 rs671 genotype, while the presence of ALDH2 rs671 risk alleles in the drinking men group with CETP rs708272 risk TT genotype was associated with changes in total cholesterol levels. This was an observational study of the association between alcohol consumption and cholesterol according to CETP and ALDH2 variants. Residual confounding is a critical issue that should be considered in observational studies. We replicated two Korean population cohorts (HEXA and KNHANES) to address residual confounding. In the present study, we revealed differences in HDL-cholesterol according to the presence of CETP rs708272, independent of ALDH2 rs671 and alcohol consumption, and found that the presence of CETP rs708272 risk allele in men was associated with an increase in HDL cholesterol following alcohol intake. Furthermore, total cholesterol levels were associated with alcohol consumption and ALDH2 rs671 in men with CETP rs708272 CT and TT genotypes with strong genetic effects. This study provides information about genetic variants of CETP and ALDH2 in the Korean population. It clarifies the probable mechanism underlying the differential association between alcohol consumption and cholesterol (total cholesterol and HDL-C) according to CETP and ALDH2 variants. Overall, our work would be helpful in clarifying the clinical implications of improving the translational value for preventive management of public health policies, and further realizing personalized or precision medicines that can prevent individual diseases or realize early detection, treatment decisions, and prognosis. It can also be used as a predictor of population assessment and vulnerable groups, while providing evidence for health policy development and health insurance applications.

Methods

Study population

Data were obtained from two studies conducted by the Korea Disease Control and Prevention Agency (KDCA) as part of the Korean Genome and Epidemiology Study (KoGES) and the KNHANES. Written informed consent was obtained from all participants, and the research project was approved by KDCA. The study protocol was approved by the Institutional Review Board of the Korean National Institute of Health (2019-03-01-PE-A). HEXA and KNHANES have been previously described in detail[34]. All study protocols were carried out by the approved guidelines. The HEXA cohort subjects (n = 53,754) were invited to health examination centers in eight regions (metropolitan areas or major cities) and enrolled in 38 health examination centers and hospitals in Korea between 2004 and 2013. Individuals with missing data for the CETP rs708272 genotype (n = 149) or alcohol consumption (n = 2256) were excluded. A total of 51,349 participants were included in this cross-sectional study. KHNANES is a nationally representative survey of the health and nutritional status of the Korean population. We used data from a population of 15,000 people aged 20–60 years collected during the 2009–2015 period. Individuals with missing data for alcohol consumption (n = 401), cholesterol (HDL and total cholesterol, n = 153), and those under 40 years of age (n = 5288) were excluded. In total, 9158 participants were included in this cross-sectional study.

Anthropometric and biochemical analyses

In HEXA, age and smoking status information was obtained using interview-based questionnaires. Body mass index (BMI) was calculated as weight divided by height squared. The lipid profile (total cholesterol, TGs, and HDL-C) and fasting glucose, ALT, and AST levels were measured using a Hitachi 747 chemistry analyzer (Hitachi, Ltd., Tokyo, Japan). Systolic/diastolic blood pressure was measured twice using a standard mercury sphygmomanometer, and the results were averaged. In the KNHANES, data were collected by various means, including interview-based and self-reported questionnaires, physical examinations, and assessments of nutritional status. The calculation of BMI and blood pressure (systolic and diastolic) was the same as that for HEXA. The lipid profile (total cholesterol, TGs, and HDL-C) and plasma glucose, ALT, and AST levels were measured using a Hitachi Automatic Analyzer 7600 (Hitachi, Tokyo, Japan). Alcohol consumption data were collected using an interview-based questionnaire in HEXA and KNHNES. Subjects were asked whether they had ever consumed at least one alcoholic drink every month, and if they had, whether they were former-drinker or current drinkers[35].

Genotyping

HEXA cohort subjects were genotyped using a Korean chip designed by the Center for Genome Science at the Korean National Institute of Health. The chip was provided and its use was approved by the National Biobank of Korea, the Centers for Disease Control and Prevention, Republic of Korea (No. 2019-022). The genotyping protocol and quality control process has been described in detail previously[36]. We preliminarily analyzed the association between cholesterol and genes using 128 SNPs related to alcohol metabolism which were selected from the KNHANES by TaqMan genotyping assay as previously described[37]. Only CETP rs708272 and ALDH2 rs671 were related to cholesterol in two sets of Korean population data, which led to the use of this study.

Statistical analysis

Statistical analyses were performed using SAS software package (ver. 9.4; SAS Institute Inc., Cary, NC, USA). Data are presented as the mean ± standard deviation or number (%). Logarithmic transformation was applied to variables with a non-Gaussian distribution. Student’s t-tests were conducted to compare clinical characteristics according to sex, and chi-square tests were used for categorical variables (ALDH2, CETP, and alcohol consumption). Analysis of variance was conducted to compare alcohol consumption according to CETP and ALDH2 genotypes. Multivariable linear regression models were used to assess differences in variables between CETP and ALDH2 genotypes and the combined effects of CETP and ALDH2 on the association between alcohol consumption and cholesterol, adjusted for age, BMI, and smoking. Statistical tests were two sided, and values of p < 0.05 were considered indicative of statistical significance. Supplementary Information.
  37 in total

1.  The role of HDL cholesterol in metabolic syndrome predicting cardiovascular events. The Gubbio population study.

Authors:  A Menotti; M Lanti; A Zanchetti; G Botta; M Laurenzi; O Terradura-Vagnarelli; M Mancini
Journal:  Nutr Metab Cardiovasc Dis       Date:  2010-02-18       Impact factor: 4.222

2.  Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII.

Authors:  F Gottrand; L Beghin; N Duhal; B Lacroix; J P Bonte; J C Fruchart; G Luc
Journal:  Eur J Clin Invest       Date:  1999-05       Impact factor: 4.686

3.  Association between the incidence of hypertension and alcohol consumption pattern and the alcohol flushing response: A 12-year follow-up study.

Authors:  Min-Gyu Yoo; Yoo Jeong Lee; Han Byul Jang; Hyo-Jin Kim; Hye-Ja Lee; Sang Ick Park
Journal:  Alcohol       Date:  2020-07-21       Impact factor: 2.405

4.  Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol.

Authors:  M Hannuksela; Y L Marcel; Y A Kesäniemi; M J Savolainen
Journal:  J Lipid Res       Date:  1992-05       Impact factor: 5.922

5.  Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men.

Authors:  P J Talmud; E Hawe; K Robertson; G J Miller; N E Miller; S E Humphries
Journal:  Ann Hum Genet       Date:  2002-03       Impact factor: 1.670

Review 6.  Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese.

Authors:  Makoto Nagano; Shizuya Yamashita; Ken-Ichi Hirano; Mayumi Takano; Takao Maruyama; Mitsuaki Ishihara; Yukiko Sagehashi; Takeshi Kujiraoka; Kazuya Tanaka; Hiroaki Hattori; Naohiko Sakai; Norimichi Nakajima; Tohru Egashira; Yuji Matsuzawa
Journal:  J Atheroscler Thromb       Date:  2004       Impact factor: 4.928

7.  Alcohol consumption and cardiovascular risk factors in older lifelong wine drinkers: the Italian Longitudinal Study on Aging.

Authors:  E Perissinotto; A Buja; S Maggi; G Enzi; E Manzato; E Scafato; G Mastrangelo; A C Frigo; A Coin; G Crepaldi; G Sergi
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-08-19       Impact factor: 4.222

8.  P450 (Cytochrome) Oxidoreductase Gene (POR) Common Variant (POR*28) Significantly Alters CYP2C9 Activity in Swedish, But Not in Korean Healthy Subjects.

Authors:  Fazleen H M Hatta; Eleni Aklillu
Journal:  OMICS       Date:  2015-12

Review 9.  Associations of Cholesteryl Ester Transfer Protein TaqIB Polymorphism with the Composite Ischemic Cardiovascular Disease Risk and HDL-C Concentrations: A Meta-Analysis.

Authors:  Shu-Xia Guo; Ming-Hong Yao; Yu-Song Ding; Jing-Yu Zhang; Yi-Zhong Yan; Jia-Ming Liu; Mei Zhang; Dong-Sheng Rui; Qiang Niu; Jia He; Heng Guo; Ru-Lin Ma
Journal:  Int J Environ Res Public Health       Date:  2016-09-05       Impact factor: 3.390

10.  Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China.

Authors:  Iona Y Millwood; Robin G Walters; Xue W Mei; Yu Guo; Ling Yang; Zheng Bian; Derrick A Bennett; Yiping Chen; Caixia Dong; Ruying Hu; Gang Zhou; Bo Yu; Weifang Jia; Sarah Parish; Robert Clarke; George Davey Smith; Rory Collins; Michael V Holmes; Liming Li; Richard Peto; Zhengming Chen
Journal:  Lancet       Date:  2019-04-04       Impact factor: 202.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.